Iran moving towards bio drug export to Europe

Business Materials 12 June 2015 16:44 (UTC +04:00)

Tehran, Iran, June 13

By Mehdi Sepahvand - Trend:

The Iranian Society of Manufacturers and Exporters of Medical Biotech Products (SEMBio) is pursuing the opportunity to export products to Europe.

The company's products registration in the EU is underway, so it is hoped that by 2018 SEMBio will start exporting products to the EU, Dr Amir Hossein Kargah, secretary of the association's board told Trend June 11 on the sidelines of the Tehran innovation and technology show INOTEX 2015.

He said the association has 30 companies as members, which produce a wide range of products from drugs, lab and diagnostic kits, and blood-related products to intermediate goods and equipment needed for producing medical products.

Kargah said currently four fifth of the companies' export goes to Russia. Russia applies European standards for imports.

Iran's total drug export to Russia is $30 million. Iran is planning to increase that number to $300 million per year in the near future.

The association is also exporting products to Iraq, Syria, Kazakhstan, and Pakistan and has conducted technology export to Turkey and Malaysia, he added.

SEMBio's share of Iran's drug export is 25 percent.

Iran's medicine export will rise to $300 million in the current Iranian fiscal year, which began on March 21, said Abdorrasoul Dinarvand, Iranian deputy health minister, May 13.

Last year, the country exported $185 million of medicine, he said, adding that medicine exports will surge to $500 million over the next three years, Iran's IRIB reported on May 13.

Edited by CN

Follow the author on Twitter @mehdisepahvand